Market revenue in 2022 | USD 8.0 million |
Market revenue in 2030 | USD 11.7 million |
Growth rate | 4.9% (CAGR from 2022 to 2030) |
Largest segment | Morphine |
Fastest growing segment | Bupivacaine |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide, Other Type |
Key market players worldwide | Medtronic PLC, Smiths Group PLC, Teleflex Inc, Johnson & Johnson, Medallion Therapeutics, Tricumed Medical Technology, Arrow International Inc, Flowonix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intrathecal pumps market will help companies and investors design strategic landscapes.
Morphine was the largest segment with a revenue share of 31.25% in 2022. Horizon Databook has segmented the Italy intrathecal pumps market based on baclofen, bupivacaine, clonidine, morphine, ziconotide, other type covering the revenue growth of each sub-segment from 2017 to 2030.
Growing prevalence of cancer in Italy is expected to contribute to the market growth. As per WHO, in 2020, 415,269 new cancer cases were recorded in Italy. Around 5% to 15% of cancer patients suffer from refractory pain and require an intrathecal drug delivery technique for pain management.
Similarly, growing incidence of stroke is also expected to drive the market. Incidence of stroke in Italy was 73,116 per year. This may increase the probability of spasticity. Intrathecal pumps help in reducing spasticity through targeted drug delivery.
Therefore, penetration of intrathecal pumps in Italy is gradually increasing. Market players such as Flowonix Medical distribute intrathecal pumps in Italy through AMS Group. AMS Group also distributes Prometra II, a next-generation intrathecal pumps to medical providers in Italy.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy intrathecal pumps market, including forecasts for subscribers. This country databook contains high-level insights into Italy intrathecal pumps market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account